Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

InnoBio Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 11
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.21
Exits 8
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Health Diagnostics
  • Life Science
Summary

The main department of described VC is located in the Maisons-alfort. The company was established in Europe in France.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight DBV Technologies, Poxel, Millendo Therapeutics. Among the most popular fund investment industries, there are Therapeutics, Pharmaceutical. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France.

The usual things for fund are deals in the range of 10 - 50 millions dollars. This InnoBio Fund works on 41 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2017. The fund is constantly included in less than 2 deals per year. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2010.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the InnoBio Fund, startups are often financed by Sofinnova Partners, OUP (Osage University Partners), Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Andera Partners, Omnes Capital, Amundi Private Equity Funds. In the next rounds fund is usually obtained by Andera Partners, Kreos Capital, Bpifrance.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of InnoBio Fund:
Typical Co-investors
InnoBio Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after InnoBio Fund:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aviv Growth Partners Boston, Massachusetts, United States
Caber Partners Central, Central Region, Singapore
CFM Investments China, Guangdong, Shenzhen
Curology California, San Francisco, United States
Digital Networks -
JGE Capital Management California, San Francisco, United States
M13 California, Santa Monica, United States
Miston Espoo, Finland, Uusimaa
Monday Capital England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AlgoTherapeutix

Biotechnology
Information Technology
Pharmaceutical
$23M14 Mar 2023 Suresnes, Ile-de-France, France

Biotechnology
Life Science
Therapeutics
07 Jul 2020 France, Ile-de-France, France

Pixium Vision

3D Technology
Health Care
Information Technology
Software
$17M25 Nov 2013 France, Ile-de-France

Poxel

Biotechnology
Health Diagnostics
Pharmaceutical
$15M18 Dec 2012 France, Auvergne-Rhône-Alpes

TxCell

Biotechnology
Pharmaceutical
Therapeutics
$14M26 Nov 2012 France, Provence-Alpes-Côte d'Azur

DBV Technologies

Biopharma
Biotechnology
Health Care
Health Diagnostics
$25M05 Jan 2011 France, Ile-de-France

Poxel

Biotechnology
Health Diagnostics
Pharmaceutical
$21M08 Jul 2010 Lyon, Auvergne-Rhône-Alpes, France

Genticel

Biotechnology
Medical Device
Therapeutics
$17M05 Apr 2010 France, Ile-de-France

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent InnoBio Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 14
Average round size 16M
Peak activity year 2010
Lead investments 1
Follow on index 0.21
Exits 8
Group Appearance index 0.93

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

AlgoTherapeutix

Biotechnology
Information Technology
Pharmaceutical
$23M14 Mar 2023 Suresnes, Ile-de-France, France

Biotechnology
Life Science
Therapeutics
07 Jul 2020 France, Ile-de-France, France

Pixium Vision

3D Technology
Health Care
Information Technology
Software
$17M25 Nov 2013 France, Ile-de-France

Poxel

Biotechnology
Health Diagnostics
Pharmaceutical
$15M18 Dec 2012 France, Auvergne-Rhône-Alpes

TxCell

Biotechnology
Pharmaceutical
Therapeutics
$14M26 Nov 2012 France, Provence-Alpes-Côte d'Azur

DBV Technologies

Biopharma
Biotechnology
Health Care
Health Diagnostics
$25M05 Jan 2011 France, Ile-de-France

Poxel

Biotechnology
Health Diagnostics
Pharmaceutical
$21M08 Jul 2010 Lyon, Auvergne-Rhône-Alpes, France

Genticel

Biotechnology
Medical Device
Therapeutics
$17M05 Apr 2010 France, Ile-de-France
Crunchbase icon

Content report

The following text will be sent to our editors: